Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fennec Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Fennec Pharmaceuticals

Fennec Pharmaceuticals

Public

Fennec Pharmaceuticals: Biotech firm developing drugs to prevent ototoxicity in pediatric patients.

HQ
Triangle (historical), NC, US
Founded
1996
Overview
Compare
Fundraising
Employees
Website

Fennec Pharmaceuticals, founded with a mission to improve the lives of pediatric cancer patients, is a biopharmaceutical company focused on developing Sodium Thiosulfate to prevent platinum-induced ototoxicity. The company's core vision is to ensure that children undergoing chemotherapy can maintain their hearing, thus enhancing their quality of life. Fennec Pharmaceuticals targets the biotechnology and healthcare market, specifically addressing the unmet needs of pediatric oncology.

Notable figures affiliated with Fennec Pharmaceuticals include its leadership team and key investors from the biotech and healthcare sectors. The company has achieved significant milestones, including the development and clinical trials of its flagship product, Sodium Thiosulfate. Fennec Pharmaceuticals has made a substantial impact by addressing a critical side effect of cancer treatment, thereby contributing to the overall well-being of young cancer patients.

Fennec Pharmaceuticals - Similar Companies

Sound Pharmaceuticals logo

Sound Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Katana Pharmaceuticals logo

Katana Pharmaceuticals

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Phoenix Biotechnology logo

Phoenix Biotechnology

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Confluence Pharmaceuticals logo

Confluence Pharmaceuticals

Phoenicis logo

Phoenicis

Nacuity Pharmaceuticals logo

Nacuity Pharmaceuticals

nacuity.com

Sea Pharmaceuticals logo

Sea Pharmaceuticals

Phanes Therapeutics logo

Phanes Therapeutics

phanesthera.com

Zenopharm logo

Zenopharm

Fennec Pharmaceuticals - Quick Facts

Who are Fennec Pharmaceuticals' competitors?

Companies similar to Fennec Pharmaceuticals include Sound Pharmaceuticals, PleoPharma, PTC Therapeutics and Katana Pharmaceuticals.

When was Fennec Pharmaceuticals founded?

Fennec Pharmaceuticals was founded in 1996.

Where is Fennec Pharmaceuticals' headquarters located?

Fennec Pharmaceuticals' headquarters is located in Triangle (historical), NC, US.

When was Fennec Pharmaceuticals' last funding round?

Fennec Pharmaceuticals' most recent funding round was for $5M (USD) in December 2023.

How much has Fennec Pharmaceuticals raised to-date?

As of Dec 5, 2023, Fennec Pharmaceuticals has raised a total of $108.3M (USD).

How many employees does Fennec Pharmaceuticals have?

Fennec Pharmaceuticals has 36 employees as of Feb 6, 2024.

Fennec Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001211583
  • ticker: FENC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research